Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06863415

Study on the Enhancement of Intestinal and Immune Functions Through Probiotic Intervention

A Study on the Safety and Effectiveness of Bifidobacterium Longum Subsp. infantisBI45 in Improving Intestinal and Immune Functions

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Wecare Probiotics Co., Ltd. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Evaluate the effectiveness and safety of Bifidobacterium longum subsp. infantis BI45 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticDietary supplement: Probiotics. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).
DIETARY_SUPPLEMENTPlaceboDietary supplement: Placebo. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).

Timeline

Start date
2025-03-15
Primary completion
2025-10-10
Completion
2025-12-25
First posted
2025-03-07
Last updated
2025-03-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06863415. Inclusion in this directory is not an endorsement.

Study on the Enhancement of Intestinal and Immune Functions Through Probiotic Intervention (NCT06863415) · Clinical Trials Directory